BNET Industries
Last Fiscal Year Sales:$708.0M
- Private
- DK
Dow Jones Description
Natural Colors, Flavors & Cultures for Food Industry Mfr; Biotechnological Services for Dairy, Agriculture & Health Food Industries; Vaccines & Diagnostic Products Mfr
President & CEO
Lars FrederiksenNumber of Employees 1,188
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Lars Frederiksen | President & CEO |
| Leif Noergood | CFO, Finance & Executive Vice President |
| Peter Olesen | Executive Vice President & Chief Science Officer, Res & Development |
| Carsten Hellmann | Executive Vice President, Sales, Global |
| Hans Thorkilgaard | Executive Vice President, Production & Supply, Global |
| Henning Jakobsen | Executive Vice President, Finance & It |
| Henrik Dalboege | Executive Vice President |
| Henrik Dalboge | Executive Vice President |
| Knud Vindfeldt | Executive Vice President, Cultures & Enzymes |
| Knud Vinfeldt | Executive Vice President, Cultures & Enzymes |
| Jesper Allentoft | Vice President, People & Org |
| Winnie Buegel | General Counsel, Legal & Vice President, Compliance |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | President & CEO | Current |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | CFO, Finance & Executive Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | Executive Vice President & Chief Science Officer, Res & Development | Current |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | Executive Vice President, Sales, Global | Current |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | Executive Vice President, Production & Supply, Global | Current |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | Executive Vice President, Finance & It | Current |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | Executive Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | Executive Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | Executive Vice President, Cultures & Enzymes | Current |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | Executive Vice President, Cultures & Enzymes | Current |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | Vice President, People & Org | Current |
| Chr. Hansen A/S | Director, HR | Former |
| Organization | Position | Status |
|---|---|---|
| Chr. Hansen A/S | General Counsel, Legal & Vice President, Compliance | Current |
| Chr. Hansen A/S | Director, Compliance | Former |
Industry Transcripts by Seeking Alpha
-
Alexza Pharmaceuticals, Inc., Q3 2009 Earnings Call Transcript
on Nov 09, 2009about ALXA
-
Salix Pharmaceuticals Ltd Q3 2009 Earnings Call Transcript
on Nov 09, 2009about SLXP
-
ACADIA Pharmaceuticals, Inc. Q3 2009 Earnings Conference Call
on Nov 09, 2009about ACAD
-
XOMA Ltd. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about XOMA
-
Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript
on Nov 06, 2009about HALO
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes

